Related Experiment Video
Updated: Jul 17, 2026
A Non-random Mouse Model for Pharmacological Reactivation of Mecp2 on the Inactive X Chromosome
Published on: May 22, 2019
DDX3X overexpression in mice can cause rapid tissue-specific toxicity and mortality
Andrea Boitnott1, Yuhui Hu1, Mary Wight-Carter2
1Department of Pediatrics, UT Southwestern Medical Center, Dallas, TX 75390, USA.
Abstract:
DEAD-Box Helicase 3 X-Linked (DDX3X) is a ubiquitously expressed RNA helicase with diverse cellular roles implicated in a neurodevelopmental disorder called DDX3X syndrome. Although DDX3X is a leading genetic cause of intellectual disability in females, there is no treatment. While gene supplementation is a plausible therapeutic strategy, previous studies suggest DDX3X is carefully regulated and dose sensitive. To understand the consequences of overexpressing DDX3X with unregulated adeno-associated virus-mediated gene supplementation, we generated a vector driving strong ubiquitous DDX3X expression and administered it through a direct cerebrospinal fluid injection in newborn mice. Mice injected with a high dose died within 1 week from myocardial degeneration. Increased expression of stress response markers together with elevated apoptotic signaling in the heart suggested activation of stress-induced apoptotic pathways. Incidental findings included excess lipid accumulation, most prominent in the liver, and other liver injury. The innate immune system was also highly activated in the heart and liver. Interestingly, the brain was overall unaffected. The results suggest that DDX3X overexpression can cause rapid transgene-driven, tissue-specific toxicity, underscoring the need for tight DDX3X gene dosage control. These findings illustrate the possibility for improper transgene expression to drive severe toxicity including death within days following administration.
Insights
Overexpressing DEAD-Box Helicase 3 X-Linked (DDX3X) via gene therapy in mice caused severe toxicity and death, highlighting the critical need for precise gene dosage control in potential treatments for DDX3X syndrome.
Area of Science:
- Genetics
- Molecular Biology
- Neuroscience
Background:
- DEAD-Box Helicase 3 X-Linked (DDX3X) is crucial for cellular functions and its deficiency causes DDX3X syndrome, a neurodevelopmental disorder.
- Currently, no treatments exist for DDX3X syndrome, making gene supplementation a potential therapeutic avenue.
Purpose of the Study:
- To investigate the consequences of unregulated DDX3X gene overexpression using adeno-associated virus (AAV) mediated gene supplementation.
- To assess the tissue-specific toxicity and safety of high-dose DDX3X gene delivery in a mouse model.
Main Methods:
- Generated an AAV vector for strong, ubiquitous DDX3X expression.
- Administered the vector via cerebrospinal fluid injection in newborn mice.
- Analyzed tissue samples for toxicity, apoptosis, immune response, and gene expression.
Main Results:
- High-dose DDX3X overexpression led to rapid death in mice within one week due to myocardial degeneration and activated apoptotic pathways in the heart.
- Significant lipid accumulation and liver injury were observed, accompanied by innate immune system activation in the heart and liver.
- The brain remained largely unaffected, indicating tissue-specific toxicity.
Conclusions:
- Unregulated DDX3X overexpression can induce rapid, severe, tissue-specific toxicity, even leading to death.
- Tight control of DDX3X gene dosage is essential for the safety of gene supplementation therapies.
- These findings underscore the potential for transgene toxicity when expression levels are not carefully regulated.
